http://www.aduromed.com/
MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean’s flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut.
(Click on link below to view a must see video.)
http://www.youtube.com/watch?v=GTpuKnWo2QI
http://www.medassets.com/
http://www.reuters.com/article/pressRelease/idUS119193+26-Mar-2009+PRN20090326
MedClean Technologies, Inc. Awarded MedAssets Supply Chain Systems Contract
Thu Mar 26, 2009 8:00am EDT
MedClean to Offer RMW Solutions to MedAssets' GPO Customer Hospitals
MedAssets (Nasdaq: MDAS) partners with healthcare providers to improve their
financial strength by implementing integrated spend management and revenue
cycle solutions that help control cost, improve margins and cash flow,
increase regulatory compliance, and optimize operational efficiency. MedAssets
serves more than 125 health systems, 3,300 hospitals and 30,000 non-acute care
healthcare providers.
http://finance.yahoo.com/q/pr?s=MDAS
(MedAssets Trades on the NASDAQ as MDAS at over $22.00+ per share.)
http://www.state.nj.us/dep/
MedClean Technologies, Inc. Approved in New Jersey
http://www.reuters.com/article/pressRelease/idUS141127%2B12-May-2009%2BPRN20090512
Garden State Hospitals Can Now Enjoy MedClean Guaranteed Saving Program
Approval Follows Joint Authorization Process by NJ Department of Environmental
Protection and NJ Department of Health and Senior Services
http://www.state.nj.us/dep/dshw/rrtp/aamwdt.04.htm
Part 1
http://biomedreports.com/articles/most-popular/19782-part-i-one-mans-trash-is-another-mans-treasure-medclean-technologies-otcmcln.html
Part 2
http://biomedreports.com/component/content/article/56-top-leading-news/20594-part-ii-medclean-prepared-for-more-growth.html
MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million
http://finance.yahoo.com/news/MedClean-Technologies-Enters-prnews-2197709155.html?x=0&.v=1
The Company agreed to sell up to 750 shares of its Series C Preferred Stock, in one or more tranches from time to time. The tranches will be sold at the Company's sole discretion, at a purchase price of $10,000 per share, for an aggregate purchase price of up to $7.5 million.
http://www.aduromed.com/efficacy/index.html
Efficacy
MedClean Technologies sets the standard for efficacy testing and validation through an ongoing commitment that has resulted in the most extensive body of work in the industry. The MedClean System meets and exceeds the most demanding standards throughout all 50 states. Our work in this area has yielded a protocol that includes significant proprietary intellectual property and is the subject of a United States patent. All MedClean efficacy testing and protocol development is conducted using actual RMW from healthcare institutions to mirror real world operations.
MedClean Technologies is committed to ongoing research and development in this area and to close collaboration with industry experts to provide continuous enhancement of its Best Practices.
http://www.aduromed.com/medclean/container.html
http://www.aduromed.com/medclean/custom.html
System Components
http://www.aduromed.com/medclean/components.html
http://www.aduromed.com/medclean/quietcarts.html
http://www.aduromed.com/medclean/lifter.html
http://www.aduromed.com/medclean/autotouch.html
http://www.aduromed.com/medclean/shredder.html
http://sterilizers360.com/sterilizers/aduramed-patent-application-becomes-medclean.html
Per Yahoo & SEC Filings:
http://knobias.10kwizard.com/filing.php?rid=12&ipage=6643130&SQDESC=SECTION_ENTIRE
http://finance.yahoo.com/q/ks?s=MCLN.OB
Outstanding Shares (OS) = 650,195,085 per SEC filing 9 Dec 09
Restricted Shares = 261.28
Float = 388.915M
Authorized Shares (AS) = 3.5B
Management Team
Joseph Esposito
Chairman and Corporate Business Advisor
http://www.aduromed.com/about/esposito.html
Mr. Esposito was elected Chairman in August 2008. He was engaged by the Company in August 2007 as a business consultant. Mr. Esposito brings a broad background of over 30 years of managing the growth and profitability of domestic and international technology companies. Recently, he spent a year advising the portfolio companies at Insight Venture Partners, a private equity firm with more than $1.5 billion under management.
Prior to joining Insight, he was President and CEO of eResearchTechnology, Inc., a leading provider of technology and services to collect, process, and distribute cardiac safety and clinical data for companies in the life sciences industry. During his tenure as President and CEO from 2001 through 2006, the company's market valuation grew from $27 million to a peak of $1.5 billion, receiving recognition from Fortune Magazine as the number two fastest growing company in America.
Scott Grisanti
President, Chief Executive Officer and Director
http://www.aduromed.com/about/grisanti.html
Mr. Grisanti was named President and CEO and also elected as a director of the Company in September, 2008. Prior to joining the Company, Mr. Grisanti was the Executive Vice President of Sales, Marketing and Services at Primavera Systems, Inc., a leading provider of program and portfolio management application software and services solutions use to manage large capital projects in targeted market segments. He led the effort to increase revenues from $108 million to $205 million projected for 2008. Prior to joining Primavera, Mr. Grisanti served as Executive Vice President of Business Development and Chief Marketing Officer for eResearchTechnology, Inc., and was a key member of the team that increased revenues from $28 million to $109 million and market capitalization from $42 million to $1.5 billion. Previously, Mr. Grisanti served in an executive sales management capacity at supply chain executive application solution providers ClearCross, Inc. and Optum, Inc.
Cheryl K. Sadowski
Chief Financial Officer and Treasurer
http://www.aduromed.com/about/sadowski.html
Ms. Kaine Sadowski has been Vice-President and Controller of the Registrant since October 2008. From August 1994 until October 2008 she held several positions at eResearchTechnology, Inc. in Bridgewater, New Jersey, including Vice President, Business Management and Senior Director, Business Management, where she was the finance person responsible for the Professional Services, Project Management, Customer Care, Research & Development, IT and Cardiac Safety Divisions.
John R. Accardi
Senior Vice President of Sales/Business Development
http://www.aduromed.com/about/accardi.html
Mr. Accardi was named Senior Vice President of Sales/Business Development in September, 2008. Prior, he was with Oracle Corporation/Siebel Systems, where he was responsible for a $40 million line of business and led sales efforts for the financial services and insurance markets in the southeast region and, earlier, served as Senior Director of Siebel’s North American Reseller Network. Previously, he served as Vice President of Worldwide Sales for Rasterex, a global provider of software and services extending the value of Auto-Cad solutions. At Rasterex, Mr. Accardi drove $15 million in first year revenue and reversed an operating loss to a profit during the same period. Previously, he served in executive management capacities at systems integrator Gary Brown & Associates and applications provider Computron Software, Inc., Ross Systems and WANG Laboratories.
David J. Laky
Senior Vice President of Client Services
http://www.aduromed.com/about/laky.html
Mr. Laky was named Senior Vice President of Client Services in October, 2008. Before joining Aduromed, he was General Manager and Senior Vice President—eClinical Group, at eResearchTechnology, Inc., where he had P&L responsibility for the company’s eClinical applications business unit. Earlier, he served eResearchTechnology as Vice President of Professional Services. Prior, he was Director of Western Region Professional Services for Computron Software, Inc. and has worked as a senior auditor and tax accountant.
http://www.cpaone.net/
Child, Van Wagoner & Bradshaw, PLLC (CVB) is a public accounting firm providing audit, tax, accounting and other business advisory services. We have offices in Salt Lake City and Kaysville, Utah in the USA, as well as in Hong Kong. Audit services focus on audits of public companies, private companies, subsidized housing, and not-for-profit entities, with in-depth expertise in international clients. Tax services focus on real estate development and high-wealth individuals.
MCLN Contact Info
http://finance.yahoo.com/q/pr?s=MCLN.OB
MedClean Technologies, Inc
3 Trowbridge Drive
Bethel, CT 06801
Phone: 203-798-1080
Fax: 203-798-0147
Web Site: http://www.aduromed.com
Daily View
Weekly View
